Amundi’s DermTech, Inc. Common Stock DMTK Stock Holding History

Amundi’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,128	Closed	-$172K	–	1652
2021 Q2	$172K	Buy	+4,128	New	+$170K	﹤0.01%	1409

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

MWA

Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return

Amundi's DMTK Position: Q3 2021 in Review

Amundi sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2021, closing a stake of 4,128 shares — an estimated $172K sold.

Amundi first reported a position in DMTK in Q2 2021 and held it in 1 quarter. The position peaked at $172K in Q2 2021. 162 funds tracked by Wall St. Rank hold DMTK as of Q3 2021.

Amundi reported no remaining DermTech, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Amundi sold 4,128 DermTech, Inc. Common Stock shares in Q3 2021, an estimated $172K.
Amundi first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
Amundi's DermTech, Inc. Common Stock position peaked at $172K in Q2 2021.
162 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2021.

Based on Amundi's 13F filing for Q3 2021, filed 15 Nov 2021.